Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Bernard

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomesF A San Lucas, K Allenson, V Bernard, et al.
Journal of the American Veterinary Medical Association|December 18, 2007
A multicenter case-control study of risk factors for equine protozoal myeloencephalitisNoah D Cohen, Robert J Mackay, Ellen Toby, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survivalC Dubot, V Bernard, M P Sablin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2017
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patientsK Allenson, J Castillo, F A San Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patientsJ Castillo, V Bernard, F A San Lucas, et al.
British Journal of Cancer|April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trialC Le Tourneau, X Paoletti, N Servant, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomesF A San Lucas, K Allenson, V Bernard, et al.
Journal of the American Veterinary Medical Association|December 18, 2007
A multicenter case-control study of risk factors for equine protozoal myeloencephalitisNoah D Cohen, Robert J Mackay, Ellen Toby, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survivalC Dubot, V Bernard, M P Sablin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2017
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patientsK Allenson, J Castillo, F A San Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patientsJ Castillo, V Bernard, F A San Lucas, et al.
British Journal of Cancer|April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trialC Le Tourneau, X Paoletti, N Servant, et al.
Pageof 10